NCT04094857View on ClinicalTrials.gov

Phase 1 Study of HBN-1

PHASE1UnknownINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

November 1, 2020

Study Completion Date

December 31, 2020

Conditions

Cardiac Arrest

Interventions

DRUG

HBN-1

Intravenous infusion

Trial Locations (2)

15261

University of Pittsburgh Medical Center, Pittsburgh

04103

Maine Medical Center, Portland

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Hibernaid, Inc

INDUSTRY